Published: March 2017
Table of Contents ( 681 KB)
|Formats||Member Price||Nonmember Price|
|Bound Version||$200 / €185||$395 / €360|
|Individual Download||$200 / €185||$395 / €360|
|Which format is right for me?|
The importance of ensuring data integrity is reflected in guidance, citations, and public comments of Regulators and Health Agencies. A number of companies have suffered serious regulatory and financial consequences as a result of unacceptable pharmaceutical data integrity practices.
The ISPE GAMP® Guide: Records and Data Integrity provides principles and practical guidance on meeting current expectations for the management of GxP regulated records and data, ensuring that they are complete, consistent, secure, accurate, and available throughout their life cycle.
This approach is intended to encourage innovation and technological advancement while avoiding unacceptable risk to product quality, patient safety, and public health.
The ISPE GAMP Guide: Records and Date Integrity is intended as a stand-alone ISPE GAMP Guide aligned with the ISPE GAMP 5: A Risk-Based Approach to Compliant GxP Computerized Systems. It has been designed so that it may be used in parallel with guidance provided in ISPE GAMP 5 and other ISPE GAMP Good Practice Guides. It replaces the previous ISPE GAMP Good Practice Guide: A Risk-Based Approach to Compliant Electronic Records and Signatures.
This Guide has been developed by the GAMP Community of Practice (CoP) of ISPE; a world-wide community of practitioners and subject matter experts who over twenty-five years have been developing internationally accepted guidance on risk-based approaches to safeguard patient safety, product quality, and data integrity.
This Guide has been produced with significant input and review from regulators worldwide, including key specialists from leading regulatory authorities working (MHRA and WHO) in this area.
The ISPE GAMP® Guide: Records and Data Integrity is intended to be a complete and comprehensive single point of reference covering the requirements, expectations, and principles of pharmaceutical data integrity. Topics covered include regulatory focus areas, the data governance framework, the data life cycle, culture and human factors, and the application of Quality Risk Management (QRM) to data integrity. As such, it is of great interest to anyone with a responsibility for ensuring data integrity, including:
Readers will gain an invaluable insight into the pressing hot topic of pharmaceutical data integrity, gaining an in-depth understanding of the key requirements and principles, and gain an awareness of practical approaches and techniques to effectively address data integrity challenges. The ISPE GAMP Guide: Records and Data Integrity will assist regulated companies and their suppliers to achieve the high level of data integrity expected by regulatory authorities worldwide.
Know Before You Go: 2017 Conference on Quality Culture & Quality Metrics
Monday, 24 Apr 2017 08.04
Just Published! Pharma Records and Data Integrity GAMP Guide
Thursday, 20 Apr 2017 10.04
Meet Jazz Pharmaceuticals – 2017 FOYA Project Execution Category Winner
Wednesday, 19 Apr 2017 11.04